SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (1839)12/7/1999 12:35:00 PM
From: pz   of 5582
 
Hank,

Further the article states....

So the 2nd clinicals are due out anyday.

Paul

''This in no way reflects on the positive results or the integrity of the study,'' said Dr. Charles
Hensley, scientific affairs director at Gel Tech. The initial internal study found that Zicam significantly
reduced the duration of the common cold.

Hensley said, ''We are continuing our research on Zicam with a separate large-scale independent
clinical study. We expect the results of that study to be announced in the near future and submitted
for publication at a later date in compliance with all required protocols.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext